Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022Ruth Offergeld, Matthias an der Heiden, T. Zeiler et al.|Pathogens|2023Cited by 21